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SUM}IARY
Oxyphenonium bromide (OxBr,  Antrenyl^)  is  the o-cyclohexyl-o-phenyl
gLyco l i c  ac i d  es te r  o f  d i e thy l - ( 2 -hyd roxy -e thy1 ) -me thy l  ammon ium b rom ide ,
a  d rug  deve loped  i n  t he  yea rs  1945  -  1950 ,  wh i ch  possesses  a  s t r ong  an t i -
chol inergic ef fect ,  The compound is appl ied in the t reatment of  spasms
i n  t h e  g a s t r o i n t e s t i n a l  L r a c t ,  b i l e  d u c t s  a n d  u r o g e n i t a l  s y s t e m ,  u l c u s  p e p -
t i cum and  as  a  componen t  o f  p reanes the t i c  med i ca t i on .  Because  o f  i r s
an t i cho l i ne rg i c  e f f ec r  OxBr  i s  a l so  app l i ed  f o r  t he  re l axa t i on  o f  smoo th
musc le  i n  che  b ronch ia l  t r ee  i n  t he  t r ea tmen t  o f  pa t i en t s  w i t h  Ch ron i c
Aspec i f i c  Resp i r a to r y  A f f ec t i ons  (CARA;  mo re  o r  l ess  equ i va len t  t e rms
a r e :  C N S L D ,  C O L D ,  t ' A s t h n a " ,  " B r o n c h i t i s " ) .
I n  gene ra l  OxBr  i s  adm in i s t e red  i n  a  dose  o f  5  -  15  mg  up  t o  4
t imes a day for  oral  use,  I  -  2 rng up to 4 t imes a day for  int ramuscular
(U"1) or  subcutaneous use and O.5 -  2 mg Eime for  int ravenous ( IV) use.
OxBr was chosen as a model  compound in order to study the ef fects
o f  a  " pu re l y "  an t i cho l i ne rg i c  d rug  i n  t he  b ronchus  obs t ruc t i on  i n  CAM,
because  OxBr  exe r t s  l i t r l e  o r  no  o the r  ac t i v i t i e s ,  such  as  an  an t i h i s t a -
m in i c  e f f ec t ,  as  p resenc  i n  a  l a rge  n tu i r be r  o f  o the r  an t i cho l i ne rg i cs ,
among which th iazinamium methylsulphate.
OxBr  i s  a  qua te rna ry  ammon ium compound  and  canno t  eas i l y  pass  l i po i d
membranes because of  i ts  ionic character  in aqueous mediur l .  f ts  pharma-
cok ine t i c s  and  pa r t i cu l a r l y  i t s  b i oava i l ab i l i t y  a f t e r  o ra l  adm in i s t r a t i on
has not  yet  been invest igated in man, probably due to the lack of  a
sens iL i ve  and  se lec t i ve  assay  me thod  f o r  OxBr  i n  b i o l og i ca l  f l u i ds  such
as plasma and ur ine.
The  a im  o f  t he  s t . udy ,  desc r i bed  i n  t h i s  t hes i s ,  was  l he  deve lop rnen t
of  a method of  determinat ion of  OxBr in p lasma and ur ine in order to
i nves t i gaEe  t he  pha rmacok ine t i c s  i n  pa t i en t s  a f t e r  s i ng le  dose  adm in i s t r a -
t i on  o f  OxBr  by  IV ,  IM  and  o ra l  r ou tes .
Th i s  Thes i s  i s  d i v i ded  i n t o  3  Pa r t s :
I n  Pa r t  I  t he  i n t r oduc t i on ,  d i v i ded  i n  2  Chap te r s  i s  g i ven .
I n  Chap te r  I  t he  cha rac te r i s t i c s  o f  OxBr ,  such  as  i t s  phys i co - chem ica l
and  pha rmaco log i ca l  p rope r t i es  a re  desc r i bed .
In Chapter 2 a survey of  the strategies and developments in the bio-
analysis of  quaternary anrnonium compounds,  part icular ly  aggravated upon
quan t i t a t i ve  ch roma tog raph i c  ana l ys i s  sys tems  i s  p resen ted .
Pa r t  I I  enc l oses  t he  b i oana l ys i s  o f  OxBr  and  i s  d i v i ded  i n  4  Chap te r s .
In Chapter 3 is  descr ibed the ion-pair  extract ion of  OxBr and benac-
tyztne methyl iodide (BenMI),  a compound wi th a strong structural  agreement.
The  gene ra l  p r i nc i p l es  o f  i on -pa i r  pa r t i t i on  a re  g i ven  as  we l l  as  t he
poss ib l e  s i de  reac t i ons  such  as  d i ssoc ja t i on  o . [  t he  i on -pa i r  i n  t he  o rga -
nic phase.  The ion-pair  extract ion of  oxyphenonium (Ox+) and methylbenac-
tyz ine (BerM-) were studied f rom aqueous medium into 1,2-dichloroethane
as  o rgan i c  phase  us i ng  i od i de ,  pe rch lo ra te  and  p i c ra te  as  coun te r  i ons .
Bes ides  i on -pa i r  pa r t i t i on ,  d i ssoc ia t i on  i n  t he  o rgan i c  phase  was  a l so
observed,  which enhanced the extract ion y ie ld in t .he organic phase in the
lowe r  concen t ra t i on  range .  Fo r  t he  i so l a t i on  o f  Ox -  f r om b io l og i ca l
f l u i ds  an  i on -pa i r  ex t r ac t i on  w i t h  pe rch lo ra te  as  a  coun te r  i on  was
chosen .
I n  Chap te r  4  t he  hyd ro l ys i s  r a te  o f  OxBr  i n  neu t ra l  and  a l ka l i ne
med ia  i s  desc r i bed .  I t  appea red ,  t ha t  OxBr  i s  r e l a t i ve l y  s t ab le  i n  neu t ra l
medium. In a lkal ine rnedium i t  rapid ly hydrolyses into cr-cyclohexyl-o-
phenyl  g lycol ic  acid and diethyl -methyl-ethanol  ammonium. This hydrolysis
enab les  sp l i f t i ng  OxBr  f o r  a t  l eas t  992  a t  a  pH  :  12  a t  a  t empe ra tu re
.  , ^ o ^o r  4 u  u  w l t n l n  J U  m l n u E e s .
I n  Chap te r  5  che  de r i va t i za t i on  i s  desc r i bed  o f  o - cyc l ohexy l - o -
phenyl  g lycol ic  acid and analogous carboxyl ic  acids wi th pentaf luorobenzyl
b rom ide  f o r  a  quan t i t a t i ve  de te rm ina t i on  o f  t hese  ac i ds  i n  t he  p i como le
range by means of  gas chromatography-electron capture detect ion.  The
de r i va t i za t i on  reac t i on  was  ca r r i ed  ou t  a f t e r  i on -pa i r  ex t r ac t i on  o f  t he
acids wi th tetrapenty lammonium as counter ion into d ichloromethane as
o rgan i c  phase ,  wh i l e  a f t e r  t ak i ng  t o  d r yness ,  t he  reac t i on  was  pe r f o rmed
in dichloromethane or acetone wi th a 1ow concentrat ion of  pentaf luoroben-
zyl  bromide.  The minimun detectable amount of  the pentaf luorobenzyl  der i -
vat ives of  the acids amounted about 100 femtogram, which is  about 500
- 1 6
a t . t o m o l  ( 5  x  l 0  m o l ) .
I n  ChapEer  6  t he  t o ta l  p rocedu re  o f  de re rm ina t i on  o f  OxBr  i n  p l asma
l 6 l
and ur ine to ruhich BenMI is  added as the internal  standard is  descr ibed.
A f t e r  i so l a t i on  by  means  o f  i on -pa i r  ex t r ac t i on  w i t h  pe rch lo ra te  as  coun -
t e r - i on  and  subsequen t  r e -ex t r ac t i on  a  hyd ro l ys i s  i s  pe r f o rmed  i n  a l ka l i ne
med ium.  The  resu l t i ng  ca rboxy l i c  ac i ds  a re  de r i va t i zed  w i t h  pen ta f l uo ro -
benzyl  bromide and determined by gas chromatography-electron capEure de-
Eec t i on .  l ' { uch  a t t en t i on  has  been  pa id  t o  avo id i ng  i n t e r f e rences  o f  o the r
ca rboxy l i c  ac i ds ,  wh i ch  may  d i s t u rb  pa r t i cu l a r l y  f a t t y  ac i ds  f r om the
b io l og i ca l  samp le  o r  p resen t  as  con tam inan t s  i n  g l asswa re  and  chem ica l s .
OxBr could be determined down to 0.5 ng/ml using 2 ml p lasma and down to
l 0  ng /m l  us i ng  0 .1  n l  u r i ne .  The  meEhod  i s  su f f i c i en t l y  sens i t i ve  f o r
t he  de te rm ina t i on  o f  OxBr  i n  p l asma  and  u r i ne  a f t e r  s i ng le  adm in i s t r a t i on
o f  t he rapeu t i c  doses  o f  OxBr .
Pa r t  I I I  goes  i n t o  t he  sub jec t  o f  t he  pha rmacok ine t i c s  o f  OxBr  i n
man  and  i s  d i v i ded  i n t o  4  ChapEers .
I n  Chap te r  7  an  i n t r oduc t i on  i s  g i ven  o f  t he  pha rmacok ine t i c s  as
fa r  as  o f  i n t e res t  f o r  adequa te l y  ana l ys i s  o f  t he  p l asma  concen t ra t i on -
t ime  cu rves  and  u r i na ry  exc re t i on  da ta  obse rved  a f ce r  lV ,  IM  and  o ra l
a d m i n i s E r a r i o n .  I n  t h i s  C h a p t e r  a t t e n t i o n  i s  a l s o  p a i d  t o  f a c E o r s ,  w h i c h
m i g h r -  i n f l u e n c e  t h e  b i o a v a i l a b i l i t y  o f  a  d r u g .  M o r e o v e r ,  i t  d e s c r i b e s
the  me thod  used  f o r  cu r ve  f i t t i ng  by  means  o f  non - l i nea r  r eg ress ion  ana -
lys is computer programs, such as NoNLIN and the inf luence of  data weigh-
t i ng .  As  a  me lhod  l o r  da ta  we ighc ing  t he  l og - f i t  app roach  i s  p roposed  i n
such  cases ,  i n  wh i ch  t he  p rec i s i on  o f  t he  da ta  po in t s  i s  unkno r ,m  and
f i r s t - o rde r  k i ne t i c s  a re  assumed .  Th i s  l og - f i t  we igh t i ng  assumes  a  con -
stant  var iance af ter  logar i thmic t ransformat ion of  the data and has
been  app l i ed  f o r  t he  ana l ys i s  o f  a l l  Ehe  p l asma  concen t ra t i on - t ime
cu rves .
I n  t . he  f o l l ow ing  Chap te r s  t he  pha rmacok ine t i c s  a re  desc r i bed  a f t e r
s i ng le  dose  adm in i s t r a t i on  o f  OxBr  i n  CAM-pa t i en t s  ( vo l un tee rs )  unde r
s tanda rd i zed  cond i t i ons ,  i n  wh i ch  t he  p l asma  concen t ra t i on ,  l ung  f unc t i on
such  as  FEVr  n  and  VC ,  and  s i de  e f f ec t s  such  as  hea r t  f r equency  du r i ng
7 hours were measured and ur ine excret ion dur ing 24 hours r^/as t raced.
I n  Chap te r  B  che  pha rmacok ine t i c s  a f t e r  IV  adm in i s t r a t i on  o f  2  mg
OxBr  a re  desc r i bed .  An  open  t h ree -compar tmen t  mode l  i s  p roposed .  The
ha rmon i c  mean  t r  e l im ina t i on  was  f ound  t o  be  I 20  m in .  The  vo lume  o f  t he
centra l  c .ompartment V^ was 2.4 h,  the volume of  d ist r ibut ion V- was 60 1.U 5
t62
and the body plasma clearance VO was 340 ml/min.
In Chaprer 9 the pharmacokinet ics are descr ibed af ter  I I . f  adrnin isura-
t ion of  2 mg OxBr.  An open lv/o-compartment model  wi th a f i rs t -order ab-
so rp t i on  and  a  l ag  c . ime  i s  p roposed .  The  l ag  t ime  was  f ound  t o  be  1 ,2  m in
the  t r  abso rp t i on  was  5  m in . ,  t he  t ,  e l im ina t i on  was  130  m in . ,  t he  Va  was
14  1 .  and  t he  VU  was  65  1 .  The  mean  b i oava i l ab i l i t y  F  ca l cu l a ted  f r om
areas under the curves was found to be 792,  The maximum plasma concentra-
t i on  was  reached  a f t e r  15  m in  and  was  f ound  t o  be  B0  ng /m l .
I n  Chap te r  I 0  t he  pha rmacok ine t i c s  a re  desc r i bed  a f t e r  o ra l  adm in i s t r a -
t i on  o f  l 0  mg  OxBr  i n  t he  f o rm  o f  2  t ab le t s  An t reny lR .  A  re l a t i ve l y  r ap id
abso rp t i on  was  f ound ,  f o l l owed  by  a  f l aE  s l ow l y  descend ing  p l asma  concen -
trat ion curve.  An open one-compartment model  is  proposed. The t '  absorp-
t i on  was  f ound  t o  be  23  m in . ,  t he  E r  e l im ina t i on  was  190  m in . ,  t he  VU  was
93  1 .  The  l onge r  t ,  e l im ina t i on  may  be  due  t o  a  p ro l onged  s l ow  ( r e )abso rp -
E ion  and  d i s t r i bu t i on  f r om the  gas t ro i n tes t i na l  and  hepa t i c  sys tems .  The
b ioava i l ab i l i t y  F  was  f ound  t o  be  62 ,  The  max imum p lasma  concen t ra t i on
of  abouE 5 ng/ml was reached af ter  about 80 min.  The mean plasma concen-
t r a t i ons  i n  t he  t e rm ina l  phase  a f t e r  o ra l  adm in i s t r a t i on  o f  l 0  mg  OxBr
was found to be somewhau higher than found af ter  IV or  IM in ject ion of
2  mg  OxBr ,  desp i t e  Ehe  l ow  b i oava i l ab i l i t y .
A l1  k i ne t i c  va l ues  men t i oned  we re  ca l cu l a ted  f r om the  means  o f
es t imaues  i n  a  g roup  o f  7  pa t i en t s .  Fo r  t he  i nd i v i dua l  daEa  and  cu rves
the  reade r  i s  r e fe r red  t o  t he  Chap te r s  conce rned .
The  exc re t i on  o f  OxBr  i n  u r i ne  a f t e r  IV ,  IM  and  o ra t  adm in i s t r aE ion
i s  a l so  desc r i bed  i n  Chap te r s  8 ,  9  and  lQ  respecL i ve l y .  The  u r i ne  was
samp ted  as  much  as  poss ib l e  eve ry  hou r  du r i ng  t he  f i r sE  7  hou rs ,  and  t hen
poo led  f r om 7  t o  24  hou rs ,  The  eva lua t i on  o f  t he  exc re f i on  ra te  as  a
func t i on  o f  t ime  appea red  t o  be  no t  we l l  poss ib l e  because  comp le te  emp ty -
ing of  Ehe ur inary b ladders was di f f icul t  part icular ly  af ter  IV and I l '1
adm in i s t r a t i on .  Th i s  may  be  due  t o  t he  an t i cho l i ne rg i c  e f f ec t  o f  OxBr  on
Ehe  smoo th  musc le  o f  t he  b l adde r .
The average renal  c learances measured over 24 hours were found to
be  190 ,  lB0  and  140  rn1 /m in  a f t e r  IV ,  IM  and  o ra l  adm in i s t r a t i on ,  r espec -
t i ve l y .  Assum ing ,  t ha t  Ox*  i s  pa r t l y  bound  t o  p l asma  p ro te i ns ,  t he  occu r -
rence of  tubular  secret ion can be taken into account beside glomerular
f i l t r a t i on .  I nd i ca t i ons  f o r  a  sa tu ra t i on  o f  t h i s  ac t i ve  sec re t i on  p rocess
were  no t  f ound .  The  coe f f i c i en t s  o f  co r re l a t i on  o f  t he  ave rage  rena l
I  O J
:
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c lea rances  a f t e r  d i f f e ren t  r ou tes  o f  adm in i s t r a t i on  i n  Ehe  g roup  o f  seven
pa t i en t s  we re  1ow .  Mo reove r ,  t he  coe f f i c i en t s  o f  co r re l a t i on  o f  t he  b i o -
avai labi l i ty  based on ur inary excret ion data and areas under the curves
was also 1ow so that  calculat ing the bioavai labi l i ty  f rom ur inary excre-
t ion data canno|  be reconrnended. The mean f ract ion of  OxBr excreted un-
changed in ur ine dur ing 24 hours were found to be 58,  59 and 477" af ter
IV ,  IM  and  o ra l  adm in i s t r a t i on ,  r espec t i ve l y ,
